The most studied longevity-adjacent fat: what the largest trials actually found.
TL;DR: Omega-3 fatty acids are among the most studied supplements for cardiovascular health. Large trials have produced mixed results, with the clearest benefits seen in people with high triglycerides. No omega-3 supplement has been proven to extend human lifespan, but they remain a low-risk option for many adults when dosed appropriately.
The three main dietary omega-3s are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). ALA is found in flaxseed, walnuts and chia and must be converted to EPA and DHA in the body — a process that is inefficient in most people. EPA and DHA are found directly in oily fish such as salmon, mackerel, sardines and anchovies.
Both EPA and DHA are incorporated into cell membranes and serve as precursors for specialised pro-resolving mediators (SPMs), which help regulate inflammation.
| Feature | EPA | DHA |
|---|---|---|
| Primary food source | Oily fish, fish oil | Oily fish, fish oil, algae |
| Key tissues | Vascular, immune | Brain, retina |
| Best-known effects | Triglyceride lowering, anti-inflammatory | Cognitive and visual development, membrane fluidity |
| Common trial dose | 1–4 g/day | 0.5–2 g/day |
Most fish-oil supplements contain both, but the ratio varies. Products high in EPA are often marketed for mood or cardiovascular support; DHA-rich products are common in pregnancy and brain-health supplements.
Bhatt et al. tested 4 g/day of prescription icosapent ethyl (a highly purified EPA ethyl ester) in people with cardiovascular disease or diabetes plus high triglycerides. It found a significant reduction in major cardiovascular events, including cardiovascular death, compared with placebo. This led to NHS approval for selected high-risk patients.
Nicholls et al. tested a carboxylic acid form of EPA/DHA in a similar population. It did not show a significant reduction in cardiovascular events and was stopped early. The mixed results suggest formulation, dose and baseline patient risk all matter.
Abdelhamid et al., 2018 and Abdelhamid et al., 2021 generally find modest cardiovascular benefit from omega-3s in high-risk groups, little or no effect on all-cause mortality in the general population, and consistent reductions in triglycerides at higher doses.
Beyond the heart, omega-3s are being studied for:
Omega-3s are generally well tolerated. Common side effects include fishy reflux, nausea and loose stools. Higher doses can increase bleeding time slightly, so people on anticoagulants (warfarin, apixaban, clopidogrel) should speak to a clinician before high-dose use. Prescription-strength omega-3s can raise atrial fibrillation risk in some patients, a signal seen in REDUCE-IT and STRENGTH.
💚 Check price on Amazon UK — omega-3 fish oil
💚 Check price on Amazon UK — algae omega-3
Affiliate ID placeholder: replace with Amazon Associates tag once configured.
These sources are referenced inline throughout the article and listed below for full transparency.
"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia." REDUCE-IT trial showing reduced major cardiovascular events with high-dose prescription EPA.
View DOI"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease." Large systematic review of omega-3 trials with mixed findings.
View DOI"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk." STRENGTH trial results.
View DOI"Omega-3 fatty acids and cardiovascular outcomes: updated systematic review and meta-analysis." Summarises effects on mortality, cardiovascular events and triglycerides.
View DOI"Effect of fish oil on cognitive performance in older adults: a randomised controlled trial." Early trial suggesting modest cognitive effects in healthy elderly.
View DOINo supplement has been proven to extend human lifespan. Large cardiovascular trials show mixed results: some find reduced risk of major cardiac events, especially in people with high triglycerides, while others find no clear effect on total mortality.
EPA and DHA are long-chain omega-3 fatty acids. EPA is more strongly linked to anti-inflammatory and triglyceride-lowering effects. DHA is a major structural component of the brain and retina and is important for cognitive and visual health.
For general health, the NHS recommends at least one portion of oily fish per week. Supplements vary widely in EPA/DHA content. For high triglycerides, prescription EPA products are used at doses of around 2 g twice daily, but this is not appropriate for everyone.
Algae oil provides DHA and often smaller amounts of EPA. It is a suitable option for vegetarians and vegans. Purity and concentration vary by product, so check the label for actual EPA and DHA content.
This article may contain affiliate links to supplement products. If you purchase through these links, LongevityTortoise may earn a small commission at no extra cost to you. This does not influence our editorial judgements.
The content on this site is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medication or have a medical condition. People on blood-thinning medication should seek medical advice before taking high-dose omega-3.